Edition:
United Kingdom

People: Amedisys Inc (AMED.OQ)

AMED.OQ on NASDAQ Stock Exchange Global Select Market

118.47USD
14 Jun 2019
Change (% chg)

$-0.18 (-0.15%)
Prev Close
$118.65
Open
$118.30
Day's High
$119.10
Day's Low
$118.06
Volume
60,059
Avg. Vol
193,771
52-wk High
$140.91
52-wk Low
$81.83

Zilkha, Nathaniel 

Mr. Nathaniel M. Zilkha is Independent Director of Amedisys, Inc. Mr. Zilkha is a Member of KKR Management LLC, which is the general partner of KKR & Co. L.P. (together with its affiliates, “KKR”). Mr. Zilkha joined KKR in 2007 and serves as the Co-Head of KKR Credit, KKR’s global credit investing business. KKR Credit invests in special situations, private credit and leveraged credit, primarily through private funds, separate accounts and CLO’s. He is also the co-portfolio manager of the KKR Special Situations funds, which he has managed since their inception in 2009. He is a member of the Private Credit Investment Committee, Special Situations Investment Committee, Credit Portfolio Management Committee and the firm-wide Investing and Distribution Committee. Mr. Zilkha also spent time as a member of KKR’s Private Equity Team in KKR’s Menlo Park office. Prior to joining KKR, Mr. Zilkha was a member of the Principal Investment Area of Goldman, Sachs & Co., where he invested in private equity and principal debt transactions. At KKR, he was formerly on the boards of Harden Healthcare, Oriental Brewery, QMH, Winoa, Hilding Anders and Jazz Pharmaceuticals. Mr. Zilkha graduated cum laude from Princeton University.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 150,032
Long-Term Incentive Plans, USD --
All Other, USD 120,000
Fiscal Year Total, USD 270,032

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Donald Washburn

368,699

Paul Kusserow

4,000,920

Scott Ginn

1,163,040

Christopher Gerard

2,583,090

Sharon Brunecz

--

Michael North

1,391,480
As Of  31 Dec 2017